-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, ErCTeM0UVDBiM7s3yTSHsmxynDaQDQam3Ma14721O4MOr5DaQRlAlu1HG+5ihNgs SmkN23qRdIkOqiT8rI0EWw== 0000821616-08-000006.txt : 20080523 0000821616-08-000006.hdr.sgml : 20080523 20080523185114 ACCESSION NUMBER: 0000821616-08-000006 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20080523 FILED AS OF DATE: 20080523 DATE AS OF CHANGE: 20080523 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BENTLEY PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000821616 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 591513162 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: BENTLEY PARK STREET 2: 2 HOLLAND WAY CITY: EXETER STATE: NH ZIP: 03833 BUSINESS PHONE: 6036586100 MAIL ADDRESS: STREET 1: BENTLEY PARK STREET 2: 2 HOLLAND WAY CITY: EXETER STATE: NH ZIP: 03833 FORMER COMPANY: FORMER CONFORMED NAME: BELMAC CORP /FL/ DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MURPHY JAMES R CENTRAL INDEX KEY: 0001218893 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-10581 FILM NUMBER: 08859203 MAIL ADDRESS: STREET 1: BENTLEY PARK STREET 2: 2 HOLLAND WAY CITY: EXETER STATE: NH ZIP: 03833 4 1 primary_doc.xml PRIMARY DOCUMENT X0202 4 2008-05-23 0 0000821616 BENTLEY PHARMACEUTICALS INC BNT 0001218893 MURPHY JAMES R BENTLEY PARK 2 HOLLAND WAY EXETER NH 03833 1 1 0 0 Chairman & CEO Common Stock, $0.02 par value 2008-05-23 4 M 0 6750 0 A 424403 D Common Stock, $0.02 par value 2008-05-23 4 M 0 4500 0 A 428903 D Common Stock, $0.02 par value 12031 I Company-sponsored 401(k) Retirement Plan Common Stock, $0.02 par value 100 I By son Restricted Stock Units 2008-05-23 4 M 0 6750 0 D Common Stock, $0.02 par value 6750 13500 D Restricted Stock Units 2008-05-23 4 M 0 4500 0 D Common Stock, $0.02 par value 4500 13500 D Represents shares issued from the vesting of restricted stock units. Represents 100 shares of Common Stock held by Mr. Murphy's son, as to which Mr. Murphy disclaims beneficial ownership. Each restricted stock unit represents a contingent right to receive one share of Bentley Pharmaceuticals, Inc. Common Stock, $0.02 par value. Restricted stock units were granted under the terms of the Company's Amended and Restated 2005 Equity and Incentive Plan. Units vest, and will be issued to the reporting person in two equal installments on 5/23/2009 and 5/23/2010. Restricted stock units were granted under the terms of the Company's Amended and Restated 2005 Equity and Incentive Plan. Units vest, and will be issued to the reporting person in three equal installments on 5/23/2009, 5/23/2010 and 5/23/2011. James R. Murphy 2008-05-23 -----END PRIVACY-ENHANCED MESSAGE-----